Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham heart study beyond LDL-C and non-HDL-C

Michael J. Pencina, Ralph B. D'Agostino, Tomasz Zdrojewski, Ken Williams, George Thanassoulis, Curt D. Furberg, Eric D. Peterson, Ramachandran S. Vasan, Allan D. Sniderman

Research output: Contribution to journalArticlepeer-review

84 Scopus citations

Fingerprint

Dive into the research topics of 'Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham heart study beyond LDL-C and non-HDL-C'. Together they form a unique fingerprint.

Medicine & Life Sciences